Aidy Boothroyd reveals Parkinson's disease diagnosis
Aidy Boothroyd has announced that he has been diagnosed with Parkinson's.
The 54-year-old revealed he had learnt of his condition more than three years ago, shortly after losing his job as England Under-21 manager.
Former Watford manager Boothroyd, who has not coached since leaving Indian Super League side Jamshedpur in 2023, said: 'The news came as a massive shock to me, following what I expected to be my routine LMA [League Managers Association] annual health assessment.
'It has taken me time to feel ready to share my diagnosis, and I have found it difficult not being completely open with people.
'Personally, my passion and love for coaching is as strong as ever, I am focusing on keeping physically fit, which is key to slowing down the progression of Parkinson's.
'I am ready to start the next chapter in my life.
'I would like to thank the LMA and Parkinson's UK for their support.'
LMA chief executive Richard Bevan said: 'Aidy has displayed incredible positivity, resolve and determination since his Parkinson's diagnosis three years ago. His passion for football and people drives him on and he continues to play an active role in the LMA, as an almost ever-present senior member at our events and educational sessions.
'We care deeply for all our members, and Aidy's attitude since his diagnosis has been an inspiration to our entire team as we continue to support him and his family throughout this unexpected and challenging time.'
Parkinson's UK CEO Caroline Rassell said: 'Everyone at Parkinson's UK sends Aidy Boothroyd our best wishes and thanks him for raising awareness of Parkinson's by publicly sharing his diagnosis.
'With more than 40 symptoms, Parkinson's is unpredictable and undoubtedly introduces new challenges, but with the right support and staying active for 2.5 hours a week people can take control of their lives.
'Aidy is now part of a community of 153,000 people in the UK who live with Parkinson's along with the millions of loved ones who support them. We are here to support them all.
'A public Parkinson's diagnosis often encourages people to think about their own health and we would encourage anyone concerned about symptoms to speak to their GP, visit parkinsons.org.uk or call the Parkinson's UK confidential helpline on 0808 800 0303.'
Former Southampton and Sheffield Wednesday manager Paul Sturrock revealed in 2008 that he had been diagnosed with Parkinson's eight years earlier. He is now 68.
Liverpool legend Ray Kennedy was diagnosed with early onset Parkinson's in 1984 at the age of 32. He died in 2021 aged 70.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wales Online
19 hours ago
- Wales Online
Changes in the mouth could be early sign of dementia in Parkinson's
Changes in the mouth could be early sign of dementia in Parkinson's The changes could be used to identify people at higher risk of worsening symptoms A woman's mouth being checked and swabbed Changes in specific bacteria in the mouth and gut of patients with Parkinson's disease could potentially be an early warning sign that symptoms of the condition are getting worse, a study suggests. With the help of artificial intelligence (AI), scientists have linked these shifts to cognitive decline – problems with memory and learning – in people with the disease. They suggest the toxins could one day be used as 'markers' for medics to pinpoint the Parkinson's patients at a higher risk of dementia, as well as being used to help develop targeted treatments for the disease. Parkinson's disease is a progressive condition that affects the brain, with symptoms including involuntary shaking, known as tremors, as well as psychological problems such as depression, loss of balance, trouble sleeping and memory issues. According to the Alzheimer's Society, around a third of people with Parkinson's eventually develop dementia. Dr Saeed Shoaie, group leader of the quantitative systems biology (QTS) lab at King's College London, said: 'The human gut and oral bacterial communities are increasingly linked to neurodegenerative diseases. 'Disruptions in the gut-brain axis could trigger inflammation and immune responses that contribute to neuronal damage. 'A common gum disease bacterium like porphyromonas gingivalis has been discovered as a potential driver of Alzheimer's.' For the study, led by experts at King's College London and published in the journal Gut Microbes, scientists analysed 228 spit and stool samples. The samples came from 41 patients with Parkinson's and mild cognitive impairment, which causes problems with thinking and memory, 47 patients with Parkinson's and dementia and 26 healthy patients. Article continues below The team found that the gut of people with mild cognitive impairment contained more harmful bacteria, many of which are likely to have come from the mouth. This bacteria releases toxins that can damage gut tissue, promote inflammation and potentially affect the brain, according to researchers. For a more in-depth analysis, the team used AI to pinpoint the bacterial species and functions not usually picked up by traditional testing, allowing them to link toxins specifically to cognitive decline. Dr Shoaie added: 'The emerging evidence underscores the potential importance of maintaining oral and gut health in mitigating or slowing neurodegenerative processes. 'As people with Parkinson's become increasingly reliant on carers, routine practices such as oral hygiene and nutritional intake may be neglected. Our findings suggest that promoting a healthy microbiome through consistent oral care, a balanced diet and potentially targeted probiotic interventions could support improved disease management in Parkinson's.' Article continues below Dr Frederick Clasen, research associate at the QTS lab, said: 'We don't yet know if the bacteria are causing the cognitive decline or if changes in the body due to Parkinson's allow these bacteria to grow. But our findings suggest they may play an active role in worsening symptoms.' Dr Clasen suggests these markers could one day be used to develop targeted treatments. "These toxins could be used as biological markers to identify patients at higher risk of dementia in Parkinson's,' he said. 'In the future, they might also be targets for new treatments that protect the brain by changing the gut environment.'
Glasgow Times
21 hours ago
- Glasgow Times
Gut bacteria changes could be ‘warning sign for worsening Parkinson's symptoms'
With the help of artificial intelligence (AI), scientists have linked these shifts to cognitive decline – problems with memory and learning – in people with the disease. They suggest the toxins could one day be used as 'markers' for medics to pinpoint the Parkinson's patients at a higher risk of dementia, as well as being used to help develop targeted treatments for the disease. Parkinson's disease is a progressive condition that affects the brain, with symptoms including involuntary shaking, known as tremors, as well as psychological problems such as depression, loss of balance, trouble sleeping and memory issues. According to the Alzheimer's Society, around a third of people with Parkinson's eventually develop dementia. Dr Saeed Shoaie, group leader of the quantitative systems biology (QTS) lab at King's College London, said: 'The human gut and oral bacterial communities are increasingly linked to neurodegenerative diseases. 'Disruptions in the gut-brain axis could trigger inflammation and immune responses that contribute to neuronal damage. 'A common gum disease bacterium like porphyromonas gingivalis has been discovered as a potential driver of Alzheimer's.' For the study, led by experts at King's College London and published in the journal Gut Microbes, scientists analysed 228 spit and stool samples. The samples came from 41 patients with Parkinson's and mild cognitive impairment, which causes problems with thinking and memory, 47 patients with Parkinson's and dementia and 26 healthy patients. The team found that the gut of people with mild cognitive impairment contained more harmful bacteria, many of which are likely to have come from the mouth. This bacteria releases toxins that can damage gut tissue, promote inflammation and potentially affect the brain, according to researchers. For a more in-depth analysis, the team used AI to pinpoint the bacterial species and functions not usually picked up by traditional testing, allowing them to link toxins specifically to cognitive decline. Dr Shoaie added: 'The emerging evidence underscores the potential importance of maintaining oral and gut health in mitigating or slowing neurodegenerative processes. 'As people with Parkinson's become increasingly reliant on carers, routine practices such as oral hygiene and nutritional intake may be neglected. 'Our findings suggest that promoting a healthy microbiome through consistent oral care, a balanced diet and potentially targeted probiotic interventions could support improved disease management in Parkinson's.' Dr Frederick Clasen, research associate at the QTS lab, said: 'We don't yet know if the bacteria are causing the cognitive decline or if changes in the body due to Parkinson's allow these bacteria to grow. 'But our findings suggest they may play an active role in worsening symptoms.' Dr Clasen suggests these markers could one day be used to develop targeted treatments. 'These toxins could be used as biological markers to identify patients at higher risk of dementia in Parkinson's,' he said. 'In the future, they might also be targets for new treatments that protect the brain by changing the gut environment.'
Leader Live
a day ago
- Leader Live
Gut bacteria changes could be ‘warning sign for worsening Parkinson's symptoms'
With the help of artificial intelligence (AI), scientists have linked these shifts to cognitive decline – problems with memory and learning – in people with the disease. They suggest the toxins could one day be used as 'markers' for medics to pinpoint the Parkinson's patients at a higher risk of dementia, as well as being used to help develop targeted treatments for the disease. Parkinson's disease is a progressive condition that affects the brain, with symptoms including involuntary shaking, known as tremors, as well as psychological problems such as depression, loss of balance, trouble sleeping and memory issues. According to the Alzheimer's Society, around a third of people with Parkinson's eventually develop dementia. Dr Saeed Shoaie, group leader of the quantitative systems biology (QTS) lab at King's College London, said: 'The human gut and oral bacterial communities are increasingly linked to neurodegenerative diseases. 'Disruptions in the gut-brain axis could trigger inflammation and immune responses that contribute to neuronal damage. 'A common gum disease bacterium like porphyromonas gingivalis has been discovered as a potential driver of Alzheimer's.' For the study, led by experts at King's College London and published in the journal Gut Microbes, scientists analysed 228 spit and stool samples. The samples came from 41 patients with Parkinson's and mild cognitive impairment, which causes problems with thinking and memory, 47 patients with Parkinson's and dementia and 26 healthy patients. The team found that the gut of people with mild cognitive impairment contained more harmful bacteria, many of which are likely to have come from the mouth. This bacteria releases toxins that can damage gut tissue, promote inflammation and potentially affect the brain, according to researchers. For a more in-depth analysis, the team used AI to pinpoint the bacterial species and functions not usually picked up by traditional testing, allowing them to link toxins specifically to cognitive decline. Dr Shoaie added: 'The emerging evidence underscores the potential importance of maintaining oral and gut health in mitigating or slowing neurodegenerative processes. 'As people with Parkinson's become increasingly reliant on carers, routine practices such as oral hygiene and nutritional intake may be neglected. 'Our findings suggest that promoting a healthy microbiome through consistent oral care, a balanced diet and potentially targeted probiotic interventions could support improved disease management in Parkinson's.' Dr Frederick Clasen, research associate at the QTS lab, said: 'We don't yet know if the bacteria are causing the cognitive decline or if changes in the body due to Parkinson's allow these bacteria to grow. 'But our findings suggest they may play an active role in worsening symptoms.' Dr Clasen suggests these markers could one day be used to develop targeted treatments. 'These toxins could be used as biological markers to identify patients at higher risk of dementia in Parkinson's,' he said. 'In the future, they might also be targets for new treatments that protect the brain by changing the gut environment.'
